A Win For Alterity Therapeutics Limited

Mon 23 Mar 20 at 05:30 PM
A Win For Alterity Therapeutics Limited

Alterity Therapeutics Limited (ATHE:NASDAQ) rocketted at $0.72, a gain of 103.6%. On Fri 20 Mar 20, ATHE:NASDAQ hit a New 2-Week Intraday Low of $0.28. From Fri 06 Mar 20, the stock recorded 20.00% Up Days and 27.27% Green Days

About Alterity Therapeutics Limited (ATHE:NASDAQ)

Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.